IMMUNE-MEDIATED NEPHRITIS

This adverse event was reported 469 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED NEPHRITIS:

# Drug Count
0 PEMBROLIZUMAB 190
1 NIVOLUMAB 159
2 CARBOPLATIN 112
3 IPILIMUMAB 104
4 DURVALUMAB 55
5 PACLITAXEL 48
6 PACLITAXEL (AIBUMIN-BOUND) 46
7 DEXAMETHASONE 39
8 DEXAMETHASONE 1.5 MG 39
9 LANSOPRAZOLE 35
See all common drugs associated with IMMUNE-MEDIATED NEPHRITIS

IMMUNE-MEDIATED NEPHRITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NAFCILLIN SODIUM 5 0.0054
1 VINORELBINE 30 0.0043
2 DOSTARLIMAB 9 0.0036
3 DURVALUMAB 55 0.0025
4 AMIFOSTINE 2 0.0025
5 IPILIMUMAB 104 0.0024
6 TREMELIMUMAB 10 0.0023
7 ENFORTUMAB VEDOTIN 17 0.0022
8 PRAZOSIN HYDROCHLORIDE 3 0.0022
9 PEMBROLIZUMAB 190 0.0018
See all drugs enriched for association with IMMUNE-MEDIATED NEPHRITIS